Distinguished guests, investors and netizens,
Hello everyone!
Welcome to the online investor exchange meeting of Beijing Heatscape Biotechnology Co., Ltd. for the initial public offering of shares and listing on the Science and Technology Innovation Board. Hereby, on behalf of the sponsor and lead underwriter of this offering, Zhongde Securities Co., Ltd., I would like to express a warm welcome to all the guests and investors who participated in this online roadshow, and express my heartfelt thanks to all colleagues from all walks of life who care about and support Zhongde Securities!
In the process of practicing, the biggest feeling of Heatscape Bio is that this is a very distinctive company. First of all, since its inception, the company has been committed to the research and development, production and sales of in vitro diagnostic products, and has basically established a complete industrial chain from antigens, antibodies, reagents to instruments. Secondly, the company attaches great importance to R & D investment, has a more prominent R & D strength, has undertaken 2 national 863 projects and 3 national science and technology major projects, of which 1 company is also the lead unit, reflecting a high R & D strength. Finally, whether it is from the characteristics of the existing core technology platform, differentiated products, or the research and development layout of cutting-edge innovative technologies, Heatscape Bio has a strong innovation gene, and I believe that everyone can have a full feeling in the next roadshow exchange.
This landing on the Science and Technology Innovation Board is both an opportunity and a new challenge for Heatscape Biology, and it is believed that through the help of the capital market and the continuous innovation of enterprises, Heatscape Biology will achieve more excellent results in the future. As the sponsor and lead underwriter of this offering, Zhongde Securities will, as always, fulfill its sponsorship responsibilities, be diligent and conscientious, honest and trustworthy, and do a good job in continuous supervision.
We sincerely hope that through this online roadshow promotion activity, the majority of investors can more comprehensively, deeply and objectively understand such a vibrant company with great development potential, understand the characteristics and development direction of Heatscape Biology, seize investment opportunities, and jointly share the growth returns of high-quality enterprises. We welcome all your questions, and look forward to your continued attention and support for the future development of Heatscape Biology.
Finally, on behalf of Zhongde Securities, I would like to wish Hotview Biologics a complete success in this offering! Thank you!